On November 18, 2026, three insiders at Royalty Pharma plc (RPRX) executed sales totaling approximately $22.34 million. EVP & CFO Terrance P. Coyne sold shares valued at $9.31 million and an additional $6.21 million, while EVP & Chairman, Partnering Christopher Hite sold shares worth $6.82 million.

These transactions occurred at prices around $68.87 and $68.15 per share. While insider selling can be motivated by various factors such as diversification or tax planning, a concentration of sales by multiple executives may attract investor attention.

Recent filings also show additional sales activity by Mr. Coyne and Mr. Hite on November 17, 2026, as well as sales by Marshall Urist on November 16, 2026.